If you’re looking to bolster your portfolio with some blue chip shares, you may want to look at the three listed below.
Here’s why these blue chip ASX 200 shares are highly rated right now:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share to look at is CSL. It is a leading biotechnology company behind the CSL Behring and Seqirus businesses. Combined, these two businesses have a portfolio of life-saving and lucrative therapies and vaccines which are generating billions of dollars in sales each year. In addition, the company invests in the region of 10% to 11% of these sales back into research and development activities every year. This ensures that CSL has a pipeline of potentially lucrative products to drive its future growth. The proposed blockbuster acquisition of Vifor Pharma will also add to its portfolio and boost its growth outlook.
Citi is a fan and has a buy rating and $335.00 price target on CSL’s shares. Its analysts believe that plasma collections will rebound beyond pre-pandemic levels this year. Citi expects this to be a big boost to investor sentiment which could support a re-rating of its shares.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a portfolio of in-demand properties with exposure to key growth markets such as ecommerce. Thanks to strong demand and a material development pipeline, Goodman has been tipped to continue its solid growth in the coming years.
The team at Citi is also very positive on Goodman. Its analysts currently have a buy rating and $29.50 price target on the company’s shares. They believe the company could outperform its earnings guidance in FY 2022.
REA Group Limited (ASX: REA)
A final ASX blue chip ASX 200 share to look at is REA Group. It is a leading provider of property and property-related services via websites and mobile apps across Australia and Asia. It is best-known for the realestate.com.au website which is dominating the ANZ market with 3.3 times more site visits than its nearest competitor. Looking ahead, thanks to this dominance, a strong housing market, and new acquisitions and revenue streams, REA Group appears well-positioned for long term growth.
Goldman Sachs is very positive on the company’s outlook. The broker currently has a buy rating rating and $167.00 price target on its shares.
The post 3 buy-rated blue chip ASX 200 shares according to experts appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
- We stopped buying tech, but just picked up these 2 ASX shares: expert
- Why buying ASX dividend shares based only on yield can deliver poor results: fundie
- Why expert says this supermarket ASX share is a better bet than Woolworths (ASX:WOW)
- Do ASX biotech shares offer ‘good buying’ after the sell-off? Experts weigh in
- 2 highly rated ASX shares analysts are tipping as buys
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia has recommended REA Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/lu0dthy